EUVIMEDEUVIMED entdecken
Querschnittstudie

Clinical, serological, and hematological profiles according to age at diagnosis in primary Sjögren disease: a single-center cross-sectional study

Gulnur Celik Yilmaz, Hakan Apaydin, Ruveyda Sak Inal, Ayse Tugcenur Temiz Gencoglu, Emine Gozde Aydemir Guloksuz, Murat Erdugan, Ekin Basak Doganci

Rheumatology International · 13.06.2026 · 46 (7)

DOI: 10.1007/s00296-026-06194-1 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Rheumatology International, online erschienen am 13.06.2026. Verfasst von Gulnur Celik Yilmaz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Ankara Etlik City Hospital, Ankara, Turkey. gulnurcelik61@gmail.com. Hauptthemen laut MEDLINE: Sjogren's Syndrome. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary Sjögren disease (pSjD) is a systemic autoimmune disease with heterogeneous clinical, serological, and hematological manifestations. Because symptom onset and diagnostic delay may be difficult to determine retrospectively, age at diagnosis may provide a pragmatic framework for describing clinical heterogeneity. This study compared clinical, serological, and hematological profiles across diagnosis-age groups in pSjD. This retrospective cross-sectional study included 258 patients with definite primary Sjögren disease fulfilling the 2016 ACR/EULAR classification criteria after exclusion of cases with uncertain primary/secondary status. Patients were stratified according to age at diagnosis into young-adult (< 40 years, n = 54), middle-age (40-59 years, n = 137), and late (≥ 60 years, n = 67) groups. Demographic, clinical, serological, hematological, and composite inflammatory indices were compared. Logistic regression was used to evaluate exploratory sex-adjusted associations with pulmonary involvement. ROC analysis was performed to evaluate the modest discriminative performance of RDW-SD for late versus young-adult diagnosis-age groups. Pulmonary involvement was observed in 2/54 (3.7%) young-adult, 7/137 (5.1%) middle-age, and 19/67 (28.4%) late diagnosis-age patients (p < 0.001). In exploratory sex-adjusted logistic regression, late diagnosis-age was associated with pulmonary involvement compared with young-adult diagnosis-age (OR 8.20, 95% CI 1.75-38.32), whereas middle-age diagnosis was not (OR 1.34, 95% CI 0.26-6.83). Extraglandular involvement also differed across groups (31.5%, 16.8%, and 35.8%, respectively; p = 0.006). Corticosteroid exposure was more frequent in the late diagnosis-age group (7.4%, 18.2%, and 32.8%; p = 0.002), but was interpreted as a treatment variable rather than an intrinsic disease phenotype. CRP, neutrophil count, monocyte count, RDW-SD, NLR, SIRI, SII, and AISI differed across groups. RDW-SD showed only modest discriminatory ability for late versus young-adult diagnosis-age groups (AUC 0.645, 95% CI 0.538-0.746). Autoantibody profiles were broadly comparable, although anti- SSB/La positivity was more frequent in the young-adult group. In this single-center cohort, age at diagnosis was associated with differences in selected clinical and hematological characteristics in pSjD. Late diagnosis-age was associated with a higher frequency of clinically recognized pulmonary involvement; however, this finding should be interpreted cautiously because smoking data were incomplete, HRCT screening was not systematic, age-related comorbidities were more common in older patients, and reverse causality related to ILD workup cannot be excluded. RDW-SD should be considered an exploratory CBC-derived marker with modest performance rather than a clinically established biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeHumansCross-Sectional StudiesFemaleMiddle AgedRetrospective StudiesAdultMaleAge FactorsAgedBiomarkersErythrocyte Indices

Stichwörter der Autor:innen

AdultAge of onsetAgedBiomarkersCross-sectional studiesErythrocyte indicesInflammationInterstitialLung diseasesMiddle agedNeutrophil-lymphocyte ratioRetrospective studiesSjogren’s syndrome

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Rheumatology, Ankara Etlik City Hospital, Ankara, Turkey. gulnurcelik61@gmail.com.
  • Department of Rheumatology, Ankara Etlik City Hospital, Ankara, Turkey.

Zitieren

APA

Yilmaz, G. C., Apaydin, H., Inal, R. S., Gencoglu, A. T. T., Guloksuz, E. G. A., Erdugan, M., & Doganci, E. B. (2026). Clinical, serological, and hematological profiles according to age at diagnosis in primary Sjögren disease: a single-center cross-sectional study. Rheumatology International, 46(7). https://doi.org/10.1007/s00296-026-06194-1

Vancouver

Yilmaz GC, Apaydin H, Inal RS, Gencoglu ATT, Guloksuz EGA, Erdugan M, et al. Clinical, serological, and hematological profiles according to age at diagnosis in primary Sjögren disease: a single-center cross-sectional study. Rheumatology International. 2026;46(7). doi:10.1007/s00296-026-06194-1

BibTeX
@article{Yilmaz2026,
  author = {Yilmaz, Gulnur Celik and Apaydin, Hakan and Inal, Ruveyda Sak and Gencoglu, Ayse Tugcenur Temiz and Guloksuz, Emine Gozde Aydemir and Erdugan, Murat and Doganci, Ekin Basak},
  title = {Clinical, serological, and hematological profiles according to age at diagnosis in primary Sjögren disease: a single-center cross-sectional study},
  journal = {Rheumatology International},
  year = {2026},
  volume = {46},
  number = {7},
  doi = {10.1007/s00296-026-06194-1}
}
Kostenlos starten →